炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 记者丨韩利明 编辑丨季媛媛 12月以来,港股生物医药板块IPO市场热度持续攀升:嘉和生物、翰思艾泰、明基医院、华芢生物相继通过聆讯,和美药业、高光制药、石药创新、君赛生物陆续递交上市申请,中国证监会国际合作司亦于近期披露英硅智能境外发行上市的备案通知书。 市场表现同步释放积极信号。12月10日率先在港股敲钟的...
Source Link炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 记者丨韩利明 编辑丨季媛媛 12月以来,港股生物医药板块IPO市场热度持续攀升:嘉和生物、翰思艾泰、明基医院、华芢生物相继通过聆讯,和美药业、高光制药、石药创新、君赛生物陆续递交上市申请,中国证监会国际合作司亦于近期披露英硅智能境外发行上市的备案通知书。 市场表现同步释放积极信号。12月10日率先在港股敲钟的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.